Gameto has announced the world’s first live birth using Fertilo, a new technology that matures eggs outside the body. The birth, which took place at Santa Isabel Clinic in Lima, Peru, represents a significant advancement in fertility treatment by eliminating approximately 80% of hormone injections typically required in conventional IVF.
“We are delighted to celebrate the world’s first live birth conceived using Fertilo,” said Dr. Dina Radenkovic, CEO and co-founder of Gameto. “By overcoming the major challenges of conventional IVF, such as long treatment cycles, significant side effects, and the emotional and physical strain, Fertilo provides a potentially faster, safer, and more accessible solution for families. This milestone marks a turning point in reproductive health and highlights the first application of iPSC technology in IVF and the immense potential of our technology.”
The technology uses engineered ovarian support cells to recreate the natural egg maturation process in a laboratory setting, reducing treatment cycles from the traditional 10-14 days to just three days.
“This breakthrough represents a historic milestone in reproductive medicine,” said Dr. Luis Guzmán, Lead at Pranor Labs & Science, who oversaw the Fertilo-enabled IVF cycle that enabled the first live birth. “The ability to mature eggs outside the body with minimal hormonal intervention significantly reduces risks such as ovarian hyperstimulation syndrome and alleviates the side effects caused by high hormone doses. Fertilo is a major advancement for women who cannot tolerate or do not want to undergo the burden of the traditional IVF protocol, bringing hope and new possibilities to a broader patient population.”
The mother who delivered the first Fertilo baby shared her experience: “The Fertilo method was the preferred option compared to traditional approaches. With fewer injections and a gentler, less invasive egg retrieval process, it gave me hope and reassurance during a deeply personal journey. Fertilo’s innovative approach made the physical experience easier and also lightened the emotional burden of many hormone injections. I am profoundly grateful to the Pranor Clinic and the Gameto team for their care and dedication in making my dream of having a family a reality.”
Gameto has already received regulatory clearance in several markets including Australia, Japan, Argentina, Paraguay, Mexico, and Peru, and is preparing for Phase 3 trials in the United States.
